Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | NA | NA |
Rating | 4.0 | 4.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.92 | 1.74 |
NAV | ₹66.60 | ₹82.00 |
Fund Started | 12 Apr 2004 | 17 Nov 2003 |
Fund Size | ₹1384.52 Cr | ₹3406.09 Cr |
Exit Load | 1% for redemption within 90 days. | Exit load for units in excess of 15% of the investment, 1% will be charged for redemption within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 9.04% | 6.93% |
3 Year | 10.38% | 12.07% |
5 Year | 11.77% | 11.99% |
1 Year
3 Year
5 Year
Equity | 21.78% | 20.96% |
Cash | 4.66% | 3.94% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 2.23% |
ICICI Bank Ltd. | 2.09% |
Bharti Airtel Ltd. | 1.21% |
Bajaj Finserv Ltd. | 1.09% |
Hindalco Industries Ltd. | 0.87% |
Ultratech Cement Ltd. | 0.81% |
Tech Mahindra Ltd. | 0.80% |
Infosys Ltd. | 0.79% |
Reliance Industries Ltd. | 0.77% |
State Bank of India | 0.67% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 2.50% |
HDFC Bank Ltd. | 2.00% |
State Bank of India | 1.19% |
Axis Bank Ltd. | 1.14% |
Reliance Industries Ltd. | 1.04% |
Infosys Ltd. | 0.78% |
Larsen & Toubro Ltd. | 0.76% |
Bharti Airtel Ltd. | 0.76% |
ITC Ltd. | 0.74% |
Sun Pharmaceutical Industries Ltd. | 0.74% |
Name | Dhaval Joshi | Dhruv Muchhal |
Start Date | 21 Nov 2022 | 14 Sep 2023 |
Name
Start Date
Description | The scheme primarily seeks to generate regular income through a predominant exposure to debt and money market instruments. It also aims at capital growth through an equity exposure of maximum 25 per cent. | The scheme seeks to generate income/capital appreciation by investing primarily in debt securities, money market instruments and moderate exposure to equities. |
Launch Date | 12 Apr 2004 | 17 Nov 2003 |
Description
Launch Date